WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2015036972) SELECTIVE DOPAMINE D4 RECEPTOR AGONISTS FOR TREATMENT OF WORKING MEMORY DEFICITS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2015/036972    International Application No.:    PCT/IB2014/064470
Publication Date: 19.03.2015 International Filing Date: 12.09.2014
IPC:
A61K 31/496 (2006.01), A61K 31/4545 (2006.01), A61K 31/495 (2006.01), A61P 25/28 (2006.01), A61P 25/00 (2006.01)
Applicants: FLORIDA STATE UNIVERSITY RESEARCH FOUNDATION [US/US]; Dittmer Chemistry Building 95 Chieftan Way Suite 312 Tallahassee, Florida 32306-4391 (US).
THE GENERAL HOSPITAL CORPORATION [US/US]; 55 Fruit Street Boston, Massachusetts 02114 (US)
Inventors: BHIDE, Pradeep G.; (US).
ZHU, Jinmin; (US).
BIEDERMAN, Joseph; (US).
SPENCER, Thomas J.; (US)
Agent: JAGTIANI, Ajay; (US)
Priority Data:
61/877,417 13.09.2013 US
Title (EN) SELECTIVE DOPAMINE D4 RECEPTOR AGONISTS FOR TREATMENT OF WORKING MEMORY DEFICITS
(FR) AGONISTES SÉLECTIFS DES RÉCEPTEURS D4 DE LA DOPAMINE UTILISABLES EN VUE DU TRAITEMENT DES DÉFAILLANCES DE LA MÉMOIRE DE TRAVAIL
Abstract: front page image
(EN)Working memory deficits are treated and working memory is improved with a composition that comprises a therapeutically effective amount of one or more respective selective dopamine D4 receptor agonists and/or pharmaceutically acceptable analogs, salts or hydrates of the respective one or more selective dopamine D4 receptor agonists. This composition can be administered to a subject to improve the subject's working memory.
(FR)Les défaillances de la mémoire de travail sont traitées et la mémoire de travail améliorée au moyen d'une composition contenant une quantité thérapeutiquement efficace d'un ou plusieurs agonistes sélectifs différents des récepteurs D4 de la dopamine et/ou de sels, d'hydrates ou d'analogues pharmaceutiquement acceptables dudit ou desdits différents agonistes sélectifs des récepteurs D4 de la dopamine. Cette composition peut être administrée à un sujet afin d'améliorer sa mémoire de travail.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)